UWWC1-2DS3
** This cell line contains an expected karyotypic abnormality consistent with the phenotype indicated in the "disease" field below. Please see the karyotype report in the Product Information & Testing PDF(s) linked below for more information.
This induced pluripotent stem (iPS) cell line, which serves as a model for Down Syndrome (Trisomy 21), was created by reprogramming a trisomy of 21 (Ts21) human fibroblast line.
|
Cell Line Alias
|
2DS3 |
|
Cell Type
|
Human iPS |
|
Disease
|
Down syndrome, Trisomy 21 |
|
Genetic Alteration/Mutation
|
47,XY,+21 (Trisomy 21) |
|
Sex
|
Male |
|
Age at Collection
|
1 Months |
|
Genetically Related Cell Lines
|
|
|
Reprogramming Method
|
Non-integrating (Sendai: Oct4, Klf4, Sox2, cMyc) |
|
Provider
|
University of Wisconsin - Dr. Anita Bhattacharyya
|
|
dbGaP Data
|
|
|
hPSCReg ID
|
|
|
NIH Approval
|
|
|
Pub Med Abstract
|
|
|
Related Products
|
|
|
Collection(s)
|
Down syndrome (Bhattacharyya) Collection
|
